FDA Inspection 1066355 — Cliantha Research Ltd.
The FDA completed an inspection of Cliantha Research Ltd. on Aug 3, 2018 in Ahmedabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 3, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ahmedabad (India)
Additional details
In Vivo Bioequivalence